Mason Street Advisors’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-31,920
| Closed | -$783K | – | 732 |
|
|
2020
Q4 | $783K | Sell |
31,920
-13,820
| -30% | -$259K | 0.01% | 1030 |
|
|
2020
Q3 | $745K | Sell |
45,740
-1,064
| -2% | -$19.8K | 0.01% | 943 |
|
|
2020
Q2 | $800K | Buy |
46,804
+1,967
| +4% | +$29.2K | 0.02% | 913 |
|
|
2020
Q1 | $522K | Hold |
44,837
| – | – | 0.01% | 964 |
|
|
2019
Q4 | $1.25M | Buy |
44,837
+674
| +2% | +$16.9K | 0.02% | 798 |
|
|
2019
Q3 | $999K | Sell |
44,163
-1,963
| -4% | -$44.7K | 0.02% | 853 |
|
|
2019
Q2 | $1.16M | Sell |
46,126
-627
| -1% | -$16.8K | 0.02% | 797 |
|
|
2019
Q1 | $1.27M | Sell |
46,753
-86
| -0.2% | -$2.88K | 0.03% | 798 |
|
|
2018
Q4 | $1.55M | Sell |
46,839
-1,166
| -2% | -$46.9K | 0.04% | 610 |
|
|
2018
Q3 | $2.24M | Sell |
48,005
-460
| -0.9% | -$21.1K | 0.05% | 498 |
|
|
2018
Q2 | $2.1M | Buy |
48,465
+1,355
| +3% | +$64.9K | 0.05% | 516 |
|
|
2018
Q1 | $2.62M | Buy |
47,110
+969
| +2% | +$53.1K | 0.06% | 386 |
|
|
2017
Q4 | $2.47M | Sell |
46,141
-301
| -0.6% | -$14.2K | 0.06% | 416 |
|
|
2017
Q3 | $2M | Buy |
46,442
+1,004
| +2% | +$47.7K | 0.05% | 506 |
|
|
2017
Q2 | $2.74M | Buy |
45,438
+1,128
| +3% | +$66.9K | 0.07% | 335 |
|
|
2017
Q1 | $3.07M | Buy |
44,310
+1,080
| +2% | +$75K | 0.08% | 286 |
|
|
2016
Q4 | $2.88M | Buy |
43,230
+655
| +2% | +$42.6K | 0.08% | 294 |
|
|
2016
Q3 | $2.82M | Buy |
42,575
+152
| +0.4% | +$10.4K | 0.08% | 289 |
|
|
2016
Q2 | $3.07M | Buy |
42,423
+1,582
| +4% | +$109K | 0.09% | 243 |
|
|
2016
Q1 | $2.64M | Buy |
40,841
+1,452
| +4% | +$96.3K | 0.08% | 289 |
|
|
2015
Q4 | $2.82M | Buy |
39,389
+703
| +2% | +$52K | 0.09% | 251 |
|
|
2015
Q3 | $2.97M | Buy |
38,686
+777
| +2% | +$62.7K | 0.1% | 221 |
|
|
2015
Q2 | $2.81M | Sell |
37,909
-789
| -2% | -$56.8K | 0.09% | 260 |
|
|
2015
Q1 | $2.81M | Sell |
38,698
-323,323
| -89% | -$22.5M | 0.09% | 276 |
|
|
2014
Q4 | $23.9M | Buy |
362,021
+67,987
| +23% | +$4.15M | 0.17% | 145 |
|
|
2014
Q3 | $16.1M | Buy |
294,034
+248,003
| +539% | +$14.1M | 0.13% | 200 |
|
|
2014
Q2 | $2.68M | Sell |
46,031
-1,714
| -4% | -$101K | 0.02% | 810 |
|
|
2014
Q1 | $2.96M | Buy |
47,745
+226
| +0.5% | +$13.1K | 0.02% | 760 |
|
|
2013
Q4 | $2.54M | Sell |
47,519
-581
| -1% | -$31.2K | 0.02% | 817 |
|
|
2013
Q3 | $2.42M | Buy |
48,100
+8,900
| +23% | +$434K | 0.03% | 617 |
|
|
2013
Q2 | $1.79M | Buy |
+39,200
| New | +$1.75M | 0.02% | 714 |
|
Other funds holding MD
SV
ACH
Mason Street Advisors's MD Position: Q1 2021 in Review
Mason Street Advisors sold out of Pediatrix Medical (MD) in Q1 2021, closing a stake of 31,920 shares — an estimated $783K sold.
Mason Street Advisors first reported a position in MD in Q2 2013 and held it in 31 quarters. The position peaked at $23.9M in Q4 2014. 207 funds tracked by Wall St. Rank hold MD as of Q1 2021.
- Mason Street Advisors reported no remaining Pediatrix Medical position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 31,920 Pediatrix Medical shares in Q1 2021, an estimated $783K.
- Mason Street Advisors first reported a position in Pediatrix Medical in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Pediatrix Medical position peaked at $23.9M in Q4 2014.
- 207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.